1. Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
   Michela Terri et al, 2021, Frontiers in Immunology CrossRef
2. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization
   Xun Zhou et al, 2023, Frontiers in Immunology CrossRef
3. Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis
   Chenyu Huang et al, 2022, International Journal of Molecular Sciences CrossRef
4. Decoding the role of aldosterone in glycation-induced diabetic complications
   Mayura Apte et al, 2024, Biochemical and Biophysical Research Communications CrossRef
5. Decreasing effects of protein kinase inhibitors on the expression of NOS2 and inflammatory cytokines and on phagocytosis in rat peritoneal macrophages is partly related to repolarization
   András Hrabák et al, 2023, Molecular Immunology CrossRef
6. LCZ696, an angiotensin receptor-neprilysin inhibitor, ameliorates epithelial-mesenchymal transition of peritoneal mesothelial cells and M2 macrophage polarization
   Yan Hu et al, 2024, Renal Failure CrossRef
7. Metabolic Adaptations and Functional Activity of Macrophages in Homeostasis and Inflammation
   Taisiya R. Yurakova et al, 2024, Biochemistry (Moscow) CrossRef
8. Pharmacologic Inhibition of Histone Deacetylase 6 Prevents the Progression of Chlorhexidine Gluconate-Induced Peritoneal Fibrosis by Blockade of M2 Macrophage Polarization
   Yingfeng Shi et al, 2022, Frontiers in Immunology CrossRef
9. Knockdown of AK142426 suppresses M2 macrophage polarization and inflammation in peritoneal fibrosis via binding to c‐Jun
   Qiuyuan Shao et al, 2023, The Journal of Gene Medicine CrossRef